We further showed that the inhibition of PIP5K1α reduced the ability of PCa cells to grow in the presence of myeloid cells, suggesting that tumor cells and the tumor microenvironment may be targeted by using selective kinase inhibitors. This evidence concerns the gene PIP5K1A and posterior cortical atrophy.